Implementing a Novel Consent Process for Biospecimen Research After Newborn Screening
MICI
1 other identifier
interventional
5,980
1 country
2
Brief Summary
The purpose of this study is to implement an electronic consent education process for the retention and research use of residual dried bloodspots at four hospitals in Michigan and assess the impact of the new education, both on patients and hospital staff. The research team will recruit women who have just given birth to answer surveys about the Michigan BioTrust consent process. Surveys will be collected from participants in the hospital and again four weeks later. The research team will collect survey data from patient participants at each hospital prior to hospital staff implementation of the new education process and again after staff implementation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2024
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2023
CompletedFirst Posted
Study publicly available on registry
January 5, 2024
CompletedStudy Start
First participant enrolled
May 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2028
June 19, 2025
June 1, 2025
3.5 years
December 4, 2023
June 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Consent and biobanking knowledge scores
Knowledge will be measured with with 23 questions specific to the setting of NIPS testing, and including the multidimensional measure of informed choice (MMIC). Scored will range from 0 (no knowledge) to 23 (extremely high knowledge)
Administered immediately after the intervention and at 4 week follow-up
Decisional regret
The Residual Decisional Regret measure assesses a person's feelings of regret after making a decision. Scores range from 1 to 5 with lower scores indicating better outcomes
Administered at the 4-week follow-up
Decisional Conflict
The Decisional Conflict survey will determine participant uncertainty in the decision process. DCS score ranges from 0 (no decisional conflict) to 100 (extremely high decisional conflict)
Administered immediately after the intervention and at 4 week follow-up
Consenting rates
From the state the research team will obtain whole hospital consenting rates (people who make a decision, whether it's yes or no) for the 6-month time period before and after the Implementation
Obtained from the state 6 months after the end of data collection
Biobanking rates
The research team will summarize the percentage who opt to participate in biobanking before and after implementation using state level data
Obtained from the state 6 months after the end of data collection
Study Arms (2)
Standard of Care
NO INTERVENTIONStandard education provided about the Michigan BioTrust includes a brief verbal description from hospital staff and a brochure. Materials will be provided in English, Spanish, or Arabic.
Intervention
EXPERIMENTALThe intervention group will receive standard of care in addition to the opportunity to access a website with engaging information about the Michigan BioTrust and a 4-minute video. Materials will be provided in English, Spanish, or Arabic.
Interventions
The website offers users the opportunity to choose to watch a 4-minute video or read relevant information about Newborn Screening and the Michigan BioTrust. If they choose to read, the website is designed to present information in an engaging manner, while providing optional voiceover. The video uses a mixture of live action shots and animation, all with voiceover. All materials are available in English, Spanish and Arabic.
Eligibility Criteria
You may qualify if:
- Adult (\> 18 years)
- English, Spanish or Arabic speaking
- Just gave birth and currently a patient in the Mother \& Baby Unit in the hospital
You may not qualify if:
- Parents of infants who are born pre-term (\< 37 weeks gestation)
- Parents of infants in the Neonatal Intensive Care Unit
- Parents of infants being put up for adoption or in situations where legal guardianship is unknown at the time of birth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Utah Hospital and Clinics
Salt Lake City, Utah, 84132, United States
University of Utah, Department of Obstetrics & Gynecology
Salt Lake City, Utah, 84132, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erin Rothwell, MD
University of Utah
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 4, 2023
First Posted
January 5, 2024
Study Start
May 15, 2024
Primary Completion (Estimated)
November 15, 2027
Study Completion (Estimated)
April 30, 2028
Last Updated
June 19, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share